Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy
C Rojas-Solé, V Pinilla-González, J Lillo-Moya… - Redox …, 2024 - Taylor & Francis
Increased life expectancy, attributed to improved access to healthcare and drug
development, has led to an increase in multimorbidity, a key contributor to polypharmacy …
development, has led to an increase in multimorbidity, a key contributor to polypharmacy …
[HTML][HTML] Classical and nonclassical effects of angiotensin-converting enzyme: How increased ACE enhances myeloid immune function
As part of the classical renin-angiotensin system, the peptidase angiotensin-converting
enzyme (ACE) makes angiotensin II which has myriad effects on systemic cardiovascular …
enzyme (ACE) makes angiotensin II which has myriad effects on systemic cardiovascular …
[HTML][HTML] Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human …
TH Cummings, J Magagnoli, A Sikirzhytskaya, I Tyagin… - medRxiv, 2024 - ncbi.nlm.nih.gov
More than one million people in the United States and over 38 million people worldwide are
living with human immunodeficiency virus (HIV) infection. Antiretroviral therapy (ART) greatly …
living with human immunodeficiency virus (HIV) infection. Antiretroviral therapy (ART) greatly …